Anemia of Inflammation during Human Pregnancy Does Not Affect Newborn Iron Endowment

ConclusionsHepcidin performed better than sTfR in identifying pregnant women with NIDA, but its cost may limit its use. Maternal IDA, but not NIDA, is associated with decreased newborn iron stores, emphasizing the need to identify this cause and provide iron therapy. This trial was registered atwww.clinicaltrials.gov as NCT00486863.

https://academic.oup.com/jn/article/148/3/427/4930804?rss=1

Source: Journal of Nutrition - March 12, 2018 Category: Nutrition Source Type: research